Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 7/20 | 1.00 |
| ▸ | TSHR | P16473 | 4/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.73 |
| ▸ | MEN1 | O00255 | 2/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.72 |
| ▸ | USP2 | O75604 | 2/20 | 0.72 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.72 |
| ▸ | CYP2D6 | P10635 | 6/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.65 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.65 |
| ▸ | HPGD | P15428 | 1/20 | 0.65 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.62 |
| ▸ | ITGB3 | P05106 | 4/20 | 0.61 |
| ▸ | ITGA2B | P08514 | 4/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3095008 | 0.91 | CYP2C9 (0.83) | CYP2C9TSHRCYP3A4MEN1KMT2A | |
| SCHEMBL3088233 | 0.91 | MEN1 (0.87) | CYP2C9TSHRCYP3A4MEN1KMT2A | |
| SCHEMBL3099022 | 0.87 | CYP3A4 (0.87) | CYP2C9TSHRCYP3A4MEN1KMT2A | |
| SCHEMBL641121 | 0.86 | CYP2C9 (0.75) | CYP2C9TSHRCYP3A4USP2HIF1A | |
| SCHEMBL6603738 | 0.85 | CYP2C9 (0.73) | CYP2C9TSHRCYP3A4MEN1KMT2A | |
| SCHEMBL23126615 | 0.81 | CASP6 (0.73) | CYP2C9TSHRCYP3A4MEN1KMT2A | |
| SCHEMBL484957 | 0.81 | CYP3A4 (0.68) | CYP2C9TSHRCYP3A4MEN1KMT2A | |
| SCHEMBL484823 | 0.80 | HIF1A (0.74) | CYP2C9TSHRCYP3A4MEN1KMT2A | |
| SCHEMBL640636 | 0.80 | ITGB3 (0.67) | CYP2C9TSHRCYP3A4MEN1KMT2A | |
| SCHEMBL6132956 | 0.79 | USP2 (0.69) | CYP2C9TSHRCYP3A4MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100234340-A1 | Substituted Spiroamide Compounds | GRUENENTHAL GMBH (DE) | 2010-09-16 | — | — | US | claimed |
| US-8357717-B2 | Spiro group-containing amide compounds having bradykinin 1 receptor (B1R) activity | GRUENENTHAL GMBH (DE) | 2013-01-22 | — | — | US | disclosed |
| US-20100234340-A1 | Substituted Spiroamide Compounds | GRUENENTHAL GMBH (DE) | 2010-09-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100234340-A1 | Substituted Spiroamide Compounds | BDKRB1, BDKRB2, AVPR1B | CYP2C9 351/4885TSHR 704/4885CYP3A4 1215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.